ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세포 생존율 분석 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.9%로 25억 2,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 개인 맞춤형 의료에 대한 수요 증가, 세포 기반 연구에 대한 정부 보조금 증가, 정밀의료에 대한 관심 증가, 줄기세포 연구 및 응용 분야 성장, 자동 세포 생존율 분석기의 가용성 증가, 감염 발생률 증가, 분석 정확도 및 민감도 향상에 대한 관심 증가, 칩 기반 장기 기술 개발 증가, 재생의료에 대한 수요 증가 등에 기인합니다. 칩상 장기 기술 개발 증가, 재생의료에 대한 수요 증가 등에 기인합니다. 예측 기간 동안의 참고 자료로는 하이스루풋 스크리닝 방법의 발전, AI 및 머신러닝 알고리즘의 도입, 실시간 모니터링 시스템 개발, 자동 액체 처리 시스템 도입, 세포 생존율을 동시에 측정하는 멀티플렉스 분석법 개발, 보다 지속 가능한 친환경 시약 개발, 전기화학 분석법 발전, 확장 가능한 세포 생존율 분석법 도입 친환경 시약의 채택, 사용자 친화적인 분석 키트 개발, 전기화학 분석의 발전, 확장 가능한 세포 생존율 분석의 도입, 1차 세포 및 줄기세포에 대응하는 분석의 개발 등을 들 수 있습니다.
향후 5년간 9.9%의 성장률 전망은 지난번 예측보다 0.6% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과로 인해 영국과 스웨덴에서 수입되는 실시간 세포 분석기 및 3D 분석 키트의 비용이 상승하고, 의약품의 안전성 시험이 손상되고, 전임상 연구 비용이 20-30% 상승할 수 있어 미국의 의약품 개발에 혼란을 초래할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
세포 생존율 분석 시장의 성장은 세포 기반 치료제의 채택 증가에 의해 주도될 것으로 예측됩니다. 세포 기반 치료법은 조직 복구, 질병 치료, 기능 회복 등 다양한 의료 목적으로 살아있는 세포를 사용하는 것을 포함합니다. 이러한 추세는 생명공학의 발전, 재생의료에 대한 투자 증가, 세포치료의 수용 확대, 세포공학 및 제조의 발전으로 뒷받침되고 있습니다. 세포 생존율 분석은 치료 세포의 생존성, 기능성, 안전성을 보장하여 치료 결과와 품질 보증을 최적화함으로써 이 분야에서 중요한 역할을 하고 있습니다. 예를 들어, 미국 유전자 및 세포치료학회(American Society of Gene &&Cell Therapy)는 2023년 1분기 비 유전자 재조합 세포치료제 임상시험이 전분기 대비 증가했다고 보고하여, 세포 기반 치료제의 성장세와 이것이 세포 생존율 분석 시장에도 영향을 미치고 있음을 보여주었습니다. 세포 기반 치료의 모멘텀이 세포 생존율 분석 시장에 미치는 영향을 보여줍니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 세포 생존률 분석 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 세포 생존률 분석 시장 : 성장률 분석
세계의 세포 생존률 분석 시장 실적 : 규모와 성장, 2019-2024
세계의 세포 생존률 분석 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 세포 생존률 분석 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 세포 생존률 분석 시장 : 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
소모품
기기
세계의 세포 생존률 분석 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
기초 조사
줄기세포 연구
Drug Discovery & Development
임상 및 진단 용도
기타 용도
세계의 세포 생존률 분석 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
학술연구기관
제약 및 바이오테크놀러지 기업
병원 및 진단실험실
기타 최종사용자
세계의 세포 생존률 분석 시장 : 세분화 소모품(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
시약
키트
어세이 플레이트(96 웰 플레이트)
마이크로플레이트
세계의 세포 생존률 분석 시장 : 세분화 기기 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
분광 광도계
형광계
마이크로플레이트 리더
유세포 분석기
이미징 시스템
제7장 지역별/국가별 분석
세계의 세포 생존률 분석 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 세포 생존률 분석 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
세포 생존률 분석 시장 : 경쟁 구도
세포 생존률 분석 시장 : 기업 개요
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Danaher Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Becton, Dickinson, and Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Agilent Technologies Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Lonza Group Ltd.
PerkinElmer Inc.
Sartorius AG
Charles River Laboratories
Bio-Rad Laboratories Inc.
Bio-Techne Corporation
Beckman Coulter Inc.
Promega Corporation
Abcam Limited
MP Biomedicals
Cayman Chemical Company
Cell Signaling Technology Inc.
Enzo Biochem Inc.
Creative Bioarray
Abnova Corporation
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
세포 생존률 분석 시장(2029년) : 새로운 기회를 제공하는 국가
세포 생존률 분석 시장(2029년) : 새로운 기회를 제공하는 부문
세포 생존률 분석 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Cell viability assays are methods employed to assess the ability of cells, tissues, or organs to maintain or recover a state of survival. These assays are utilized to evaluate optimal growth conditions for cells in culture in response to external stimuli, chemicals, and medicinal treatments.
The main products associated with cell viability assays include consumables and instruments. Consumables are items used either once or replaced regularly in the assay process. They find applications in various fields such as basic research, stem cell research, drug discovery and development, clinical and diagnostic applications, and more. These products are utilized by academic and research institutes, pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, among others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The cell viability assays market research report is one of a series of new reports from The Business Research Company that provides cell viability assays market statistics, including the cell viability assays industry global market size, regional shares, competitors with cell viability assays market share, detailed cell viability assays market segments, market trends, and opportunities, and any further data you may need to thrive in the cell viability assays industry. These cell viability assays market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cell viability assays market size has grown rapidly in recent years. It will grow from $1.56 billion in 2024 to $1.73 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased investment in cancer research, growth in pharmaceutical R&D expenditure, growth in the biotechnology sector, increased advancements in cell culture techniques, rise in demand for stem cell research, rise in the need for toxicity testing, rise in the utilization of real time cell analysis systems, rise in the number of CROs (contract research organizations).
The cell viability assays market size is expected to see strong growth in the next few years. It will grow to $2.52 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rise in government funding for cell based research, increasing focus on precision medicine, growth in stem cell research and applications, increasing availability of automated cell viability analyzers, rise in the incidence of infectious diseases, increasing focus on improving assay accuracy and sensitivity, increasing awareness about the benefits of cell viability assays, rise in the development of organ on a chip technologies, increasing demand for regenerative medicine. Major trends in the forecast period include advancement in high throughput screening methods, implementation of AI and machine learning algorithms, development of real time monitoring systems, adoption of automated liquid handling systems, development of multiplex assays to simultaneously measure cell viability, adoption of more sustainable and eco-friendly reagents, development of user friendly assay kits, advancement in electrochemical assays, implementation of scalable cell viability assays, development of assays compatible with primary cells and stem cells.
The forecast of 9.9% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. drug development by increasing costs for real-time cell analyzers and 3D assay kits imported from the UK and Sweden, potentially compromising drug safety testing and raising preclinical research costs by 20-30%. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growth of the cell viability assay market is expected to be driven by the increasing adoption of cell-based therapeutics. Cell-based therapeutics involve using living cells for various medical purposes, such as tissue repair, disease treatment, and functional restoration. This trend is supported by advancements in biotechnology, rising investments in regenerative medicine, greater acceptance of cell therapies, and advancements in cell engineering and manufacturing. Cell viability assays play a crucial role in this domain by ensuring the viability, functionality, and safety of therapeutic cells, thereby optimizing treatment outcomes and quality assurance. For example, the American Society of Gene & Cell Therapy reported a rise in trials for non-genetically modified cell therapies in Q1 2023 compared to the previous quarter, indicating the increasing momentum in cell-based therapeutics and its impact on the cell viability assay market.
Leading companies in the cell viability assay market are innovating with advanced cell screening technologies to enhance the efficiency and accuracy of drug discovery processes. These technologies enable high-throughput and precise analysis of cell health and responses, thereby improving experimental conditions and therapeutic development. For instance, Arralyze, a technology company based in Germany, introduced CellShepherd, a state-of-the-art platform for single-cell analysis. Utilizing proprietary nanowell glass arrays, CellShepherd enables real-time monitoring of cell-based assays, offering precise cell dispensing, sterile co-culturing, and imaging capabilities. With AI-driven analysis ensuring accurate cell counting and tracking, CellShepherd meets the growing demand for precise single-cell research across biomedical and life science applications.
In February 2022, BD Biosciences, a US-based medical device company, acquired Cytognos, a biotechnology company headquartered in Spain. This acquisition aims to broaden BD's portfolio in areas such as blood cancer diagnostics, minimal residual disease (MRD) detection, and immune monitoring research. Cytognos specializes in providing cell viability assays and clinical flow cytometry solutions, aligning with BD Biosciences' strategic goals in advancing healthcare technologies.
Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.
North America was the largest region in the cell viability assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cell viability assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cell viability assays market consists of revenues earned by entities by providing services such as assay development services, assay validation services, cell culture services, and data analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell viability assays market also includes sales of microscopes, imaging systems, incubators, plate readers, and automated liquid handling systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cell Viability Assays Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cell viability assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cell viability assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell viability assays market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Consumables; Instruments
2) By Application: Basic Research; Stem Cell Research; Drug Discovery And Development; Clinical And Diagnostic Applications; Other Applications
3) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospital And Diagnostic Laboratories; Other End-Users
Subsegments:
1) By Consumables: Reagents; Kits; Assay Plates (96-Well plates); Microplates
2) By Instruments: Spectrophotometers; Fluorometers; Microplate Readers; Flow Cytometers; Imaging Systems
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cell Viability Assays market Characteristics
3. Cell Viability Assays market Trends And Strategies
4. Cell Viability Assays market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Cell Viability Assays Growth Analysis And Strategic Analysis Framework
5.1. Global Cell Viability Assays PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cell Viability Assays market Growth Rate Analysis
5.4. Global Cell Viability Assays Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cell Viability Assays Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cell Viability Assays Total Addressable Market (TAM)
6. Cell Viability Assays market Segmentation
6.1. Global Cell Viability Assays market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consumables
Instruments
6.2. Global Cell Viability Assays market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Basic Research
Stem Cell Research
Drug Discovery And Development
Clinical And Diagnostic Applications
Other Applications
6.3. Global Cell Viability Assays market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Academic And Research Institutes
Pharmaceutical And Biotechnology Companies
Hospital And Diagnostic Laboratories
Other End-Users
6.4. Global Cell Viability Assays Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Reagents
Kits
Assay Plates (96-Well plates)
Microplates
6.5. Global Cell Viability Assays Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Spectrophotometers
Fluorometers
Microplate Readers
Flow Cytometers
Imaging Systems
7. Cell Viability Assays market Regional And Country Analysis
7.1. Global Cell Viability Assays market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cell Viability Assays market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
